Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;1(2):e67.
doi: 10.1002/cpz1.67.

In Vivo Phage Display as a Biomarker Discovery Tool for the Complex Neural Injury Microenvironment

Affiliations

In Vivo Phage Display as a Biomarker Discovery Tool for the Complex Neural Injury Microenvironment

Briana I Martinez et al. Curr Protoc. 2021 Feb.

Erratum in

Abstract

The heterogeneous injury pathophysiology of traumatic brain injury (TBI) is a barrier to developing highly sensitive and specific diagnostic tools. Phage display, a protein-protein screening technique routinely used in drug development, has the potential to be a powerful biomarker discovery tool for TBI. However, analysis of these large and diverse phage libraries is a bottleneck to moving through the discovery pipeline in a timely and efficient manner. This article describes a unique discovery pipeline involving domain antibody (dAb) phage in vivo biopanning and next-generation sequencing (NGS) analysis to identify targeting motifs that recognize distinct aspects of TBI pathology. To demonstrate this process, we conduct in vivo biopanning on the controlled cortical impact mouse model of experimental TBI at 1 and 7 days postinjury. Phage accumulation in target tissues is quantified via titers before NGS preparation and analysis. This phage display biomarker discovery pipeline for TBI successfully achieves discovery of temporally specific TBI targeting motifs and may further TBI biomarker research for other characteristics of injury. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Phage production and purification Support Protocol: Controlled cortical impact model Basic Protocol 2: Injection and elution of phage Basic Protocol 3: Amplicon sequencing and sequence analysis.

Keywords: domain antibody fragment; next generation sequencing; phage display; traumatic brain injury.

PubMed Disclaimer

References

Literature Cited

    1. Adams, S., & Pacharinsak, C. (2015). Mouse anesthesia and analgesia. Current Protocols in Mouse Biology, 5, 51-63. doi: 10.1002/9780470942390.mo140179.
    1. Afgan, E., Baker, D., Batut, B., Van Den Beek, M., Bouvier, D., Čech, M., … Blankenberg, D. (2018). The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Research, 46, W537-W544. doi: 10.1093/nar/gky379.
    1. Alam, K. K., Chang, J. L., & Burke, D. H. (2015). FASTAptamer: A Bioinformatic toolkit for high-throughput sequence analysis of combinatorial selections. Molecular Therapy. Nucleic Acids, 4, e230. doi: 10.1038/mtna.2015.4.
    1. Bábíčková, J., Tóthová, Ľ., Boor, P., & Celec, P. (2013). In vivo phage display-a discovery tool in molecular biomedicine. Biotechnology Advances, 31, 1247-1259. doi: 10.1016/j.biotechadv.2013.04.004.
    1. Barrios, Y., Jirholt, P., & Ohlin, M. (2004). Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. Journal of Molecular Recognition, 17, 332-338. doi: 10.1002/jmr.679.

LinkOut - more resources